Chlorpyrifos (Dursban) Ddvp (Dichlorvos) Diazinon Malathion Parathion
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Emerging Technologies for Degradation of Dichlorvos: a Review
International Journal of Environmental Research and Public Health Review Emerging Technologies for Degradation of Dichlorvos: A Review Yuming Zhang 1,2, Wenping Zhang 1,2, Jiayi Li 1,2, Shimei Pang 1,2, Sandhya Mishra 1,2 , Pankaj Bhatt 1,2 , Daxing Zeng 3,* and Shaohua Chen 1,2,* 1 State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China; [email protected] (Y.Z.); [email protected] (W.Z.); [email protected] (J.L.); [email protected] (S.P.); [email protected] (S.M.); [email protected] (P.B.) 2 Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou 510642, China 3 School of Applied Chemistry and Biological Technology, Shenzhen Polytechnic, Shenzhen 518055, China * Correspondence: [email protected] (D.Z.); [email protected] (S.C.); Tel.: +86-20-8528 8229 (S.C.) Abstract: Dichlorvos (O,O-dimethyl O-(2,2-dichlorovinyl)phosphate, DDVP) is a widely acknowl- edged broad-spectrum organophosphorus insecticide and acaracide. This pesticide has been used for more than four decades and is still in strong demand in many developing countries. Extensive application of DDVP in agriculture has caused severe hazardous impacts on living systems. The International Agency for Research on Cancer of the World Health Organization considered DDVP among the list of 2B carcinogens, which means a certain extent of cancer risk. Hence, removing DDVP from the environment has attracted worldwide attention. Many studies have tested the removal of DDVP using different kinds of physicochemical methods including gas phase surface discharge plasma, physical adsorption, hydrodynamic cavitation, and nanoparticles. -
488 Subpart A—Organic Pesticide Chemicals Manufacturing
§ 455.11 40 CFR Ch. I (7–1–12 Edition) chemical products and be considered a this subpart are applicable to dis- ‘‘stand-alone’’ PFPR facility. charges resulting from the manufac- ture of the following organic active in- [43 FR 17776, Apr. 25, 1978, as amended at 50 FR 40701, Oct. 4, 1985; 51 FR 44911, Dec. 15, gredients: Aldrin, BHC, Captan, 1986; 58 FR 50689, Sept. 28, 1993; 61 FR 57548, Chlordane, DDD, DDE, DDT, Dichloran, Nov. 6, 1996] Dieldrin, Endosulfan, Endrin, Hepta- chlor, Lindane, Methoxychlor, Mirex, Subpart A—Organic Pesticide PCNB, Toxaphene, Trifluralin, Chemicals Manufacturing Azinphos Methyl, Demeton-O, Demeton-S, Diazinon, Disulfoton, Mal- Subcategory athion, Parathion Methyl, Parathion Ethyl, Aminocarb, Carbaryl, SOURCE: 43 FR 44846, Sept. 29, 1978, unless Methiocarb, Mexacarbate, Propoxur, otherwise noted. Barban, Chlorpropham, Diuron, Fenuron, Fenuron-TCA, Linuron, § 455.11 Compliance date for pretreatment standards for existing Monuron, Monuron-TCA, Neubron, sources (PSES). Propham, Swep, 2,4-D, Dicamba, Silvex, 2,4,5-T, Siduron, Perthane, and All discharges subject to Dicofol. pretreatment standards for existing (c) The intermediates used to manu- sources (PSES) in subparts A and B of facture the active ingredients and ac- this part must comply with the stand- tive ingredients used solely in experi- ards no later than September 28, 1993. mental pesticides are excluded from [61 FR 57549, Nov. 6, 1996] coverage in this subpart. Insecticidal pathogenic organisms such as Bacillus § 455.20 Applicability; description of thuringiensis, insect growth hormones, the organic pesticide chemicals plant extracts such as pyrethrins; sex manufacturing subcategory. attractants and botanicals such as Ro- (a) For the purpose of calculating and tenone are also excluded from BPT applying effluent limitations for COD, coverage in this subpart. -
Malathion General Fact Sheet
MALATHION GENERAL FACT SHEET What is malathion Malathion is an insecticide in the chemical family known as organophosphates. Products containing malathion are used outdoors to control a wide variety of insects in agricultural settings and around people’s homes. Malathion has also been used in public health mosquito control and fruit fly eradication programs. Malathion may also be found in some special shampoos for treating lice. Malathion was first registered for use in the United States in 1956. What are some products that contain malathion Products containing malathion may be liquids, dusts, wettable powders, or emulsions. There are thousands of products contain- ing malathion registered for use in the United States. Always follow label instructions and take steps to avoid exposure. If any exposures occur, be sure to follow the First Aid instructions on the product label carefully. For additional treatment advice, contact the Poison Control Center at 1-800-222-1222. If you wish to discuss a pesticide problem, please call 1-800-858-7378. How does malathion work Malathion kills insects by preventing their nervous system from working properly. When healthy nerves send signals to each other, a special chemical messenger travels from one nerve to another to continue the message. The nerve signal stops when an enzyme is released into the space between the nerves. Malathion binds to the enzyme and prevents the nerve signal from stopping. This causes the nerves to signal each other without stopping. The constant nerve signals make it so the insects can’t move or breathe normally and they die. People, pets and other animals can be affected the same way as insects if they are exposed to enough malathion. -
For Methyl Parathion
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON D.C., 20460 OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES MEMORANDUM DATE: July 31, 2006 SUBJECT: Finalization of Interim Reregistration Eligibility Decisions (IREDs) and Interim Tolerance Reassessment and Risk Management Decisions (TREDs) for the Organophosphate Pesticides, and Completion of the Tolerance Reassessment and Reregistration Eligibility Process for the Organophosphate Pesticides FROM: Debra Edwards, Director Special Review and Reregistration Division Office of Pesticide Programs TO: Jim Jones, Director Office of Pesticide Programs As you know, EPA has completed its assessment of the cumulative risks from the organophosphate (OP) class of pesticides as required by the Food Quality Protection Act of 1996. In addition, the individual OPs have also been subject to review through the individual- chemical review process. The Agency’s review of individual OPs has resulted in the issuance of Interim Reregistration Eligibility Decisions (IREDs) for 22 OPs, interim Tolerance Reassessment and Risk Management Decisions (TREDs) for 8 OPs, and a Reregistration Eligibility Decision (RED) for one OP, malathion.1 These 31 OPs are listed in Appendix A. EPA has concluded, after completing its assessment of the cumulative risks associated with exposures to all of the OPs, that: (1) the pesticides covered by the IREDs that were pending the results of the OP cumulative assessment (listed in Attachment A) are indeed eligible for reregistration; and 1 Malathion is included in the OP cumulative assessment. However, the Agency has issued a RED for malathion, rather than an IRED, because the decision was signed on the same day as the completion of the OP cumulative assessment. -
Ust Be Registered by Reregistration EPA, Based on Scientific Studies Showing That They Can Be Used Without Posing Unreasonable Risks to People Or the Environment
United States Prevention, Pesticides EPA-738-F00-009 Environmental Protection And Toxic Substances September 2000 Agency (7508C) R.E.D. FACTS Ethyl Parathion Pesticide All pesticides sold or distributed in the United States must be registered by Reregistration EPA, based on scientific studies showing that they can be used without posing unreasonable risks to people or the environment. Because of advances in scientific knowledge, the law requires that pesticides which were first registered before November 1, 1984, be reregistered to ensure that they meet today's more stringent standards. In evaluating pesticides for reregistration, EPA obtains and reviews a complete set of studies from pesticide producers, describing the human health and environmental effects of each pesticide. To implement provisions of the Food Quality Protection Act (FQPA) of 1996, EPA considers the special sensitivity of infants and children to pesticides, as well as aggregate exposure of the public to pesticide residues from all sources, and the cumulative effects of pesticides and other compounds with common mechanisms of toxicity. The Agency develops any mitigation measures or regulatory controls needed to effectively reduce each pesticide's risks. EPA then reregisters pesticides that meet the safety standard of the FQPA and can be used without posing unreasonable risks to human health or the environment. When a pesticide is eligible for reregistration, EPA explains the basis for its decision in a Reregistration Eligibility Decision (RED) document. This fact sheet serves as and explains the Agency’s Reregistration Eligibility Decision for case 0155, ethyl parathion. Use Profile Ethyl parathion is a restricted use organophosphate insecticide/miticide used to control a broad spectrum of pests on alfalfa, barley, canola, corn, cotton, sorghum, soybeans, sunflowers, and wheat. -
US EPA, Pesticide Product Label, ORTHO MALATHION 50 INSECT
23V 73^ f UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 Jff***^ OFFICE OF WAV 00 Onit CHEMICAL SAFETY AND MAY 4 0 201] POLLUTION PREVENTION James Wallace The Scotts Company d/b/a The Ortho Group P.O.Box 190 Marysville, OH 43040 Subject: Submission of amended labeling per May 2009 Malathion RED Label Table EPA Reg. No. 239-739 Submissions dated March 5, 2010 Dear Mr. Wallace: The proposed labeling referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), is acceptable under FIFRA § 3(c)(5) provided that you submit two copies of your final printed label before you release the product for shipment. Products shipped after 12 months from the date of this amendment or the next printing of the label whichever occurs first, must bear the new revised label. Your release for shipment of the product bearing the amended label constitutes acceptance of these conditions. If these conditions are not complied with, the registration will be subject to cancellation in accordance with FIFRA sec. 6(e). The Basic Confidential Statement of Formula (CSF) dated 2/19/10 is acceptable. All other CSF's including Alternates have been superseded by this new CSF. This has been added to your record. Your product has met and complied with the risk mitigation provisions of the Malathion RED and therefore your product is reregistered pursuant to FIFRA § 4(g)(2)(C). But note, EPA is currently reassessing the cumulative impacts of organophosphates and that review may impact your product once complete. -
Malathion) Lotion, 0.5% Rx Only
NDC 51672-5276-4 Ovide® (malathion) Lotion, 0.5% Rx Only For topical use only. Not for oral or ophthalmic use. DESCRIPTION OVIDE Lotion contains 0.005 g of malathion per mL in a vehicle of isopropyl alcohol (78%), terpineol, dipentene, and pine needle oil. The chemical name of malathion is (±) - [(dimethoxyphosphinothioyl) - thio] butanedioic acid diethyl ester. Malathion has a molecular weight of 330.36, represented by C10H19O6PS2, and has the following chemical structure: CLINICAL PHARMACOLOGY Malathion is an organophosphate agent which acts as a pediculicide by inhibiting cholinesterase activity in vivo. Inadvertent transdermal absorption of malathion has occurred from its agricultural use. In such cases, acute toxicity was manifested by excessive cholinergic activity, i.e., increased sweating, salivary and gastric secretion, gastrointestinal and uterine motility, and bradycardia (see OVERDOSAGE). Because the potential for transdermal absorption of malathion from OVIDE Lotion is not known at this time, strict adherence to the dosing instructions regarding its use in children, method of application, duration of exposure, and frequency of application is required. INDICATIONS AND USAGE OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair. CONTRAINDICATIONS OVIDE Lotion is contraindicated for neonates and infants because their scalps are more permeable and may have increased absorption of malathion. OVIDE Lotion should also not be used on individuals known to be sensitive to malathion or any of the ingredients in the vehicle. WARNINGS 1. OVIDE Lotion is flammable. The lotion and wet hair should not be exposed to open flames or electric heat sources, including hair dryers and electric curlers. -
Nerve Agent - Lntellipedia Page 1 Of9 Doc ID : 6637155 (U) Nerve Agent
This document is made available through the declassification efforts and research of John Greenewald, Jr., creator of: The Black Vault The Black Vault is the largest online Freedom of Information Act (FOIA) document clearinghouse in the world. The research efforts here are responsible for the declassification of MILLIONS of pages released by the U.S. Government & Military. Discover the Truth at: http://www.theblackvault.com Nerve Agent - lntellipedia Page 1 of9 Doc ID : 6637155 (U) Nerve Agent UNCLASSIFIED From lntellipedia Nerve Agents (also known as nerve gases, though these chemicals are liquid at room temperature) are a class of phosphorus-containing organic chemicals (organophosphates) that disrupt the mechanism by which nerves transfer messages to organs. The disruption is caused by blocking acetylcholinesterase, an enzyme that normally relaxes the activity of acetylcholine, a neurotransmitter. ...--------- --- -·---- - --- -·-- --- --- Contents • 1 Overview • 2 Biological Effects • 2.1 Mechanism of Action • 2.2 Antidotes • 3 Classes • 3.1 G-Series • 3.2 V-Series • 3.3 Novichok Agents • 3.4 Insecticides • 4 History • 4.1 The Discovery ofNerve Agents • 4.2 The Nazi Mass Production ofTabun • 4.3 Nerve Agents in Nazi Germany • 4.4 The Secret Gets Out • 4.5 Since World War II • 4.6 Ocean Disposal of Chemical Weapons • 5 Popular Culture • 6 References and External Links --------------- ----·-- - Overview As chemical weapons, they are classified as weapons of mass destruction by the United Nations according to UN Resolution 687, and their production and stockpiling was outlawed by the Chemical Weapons Convention of 1993; the Chemical Weapons Convention officially took effect on April 291997. Poisoning by a nerve agent leads to contraction of pupils, profuse salivation, convulsions, involuntary urination and defecation, and eventual death by asphyxiation as control is lost over respiratory muscles. -
3-27-2017 Nerve Agents
Week of March 13, 2017 – Nerve Agents Last month, on February 13, Kim Jong-nam, the exiled half-brother of North Korea's ruler, Kim Jong Un, was murdered by having the nerve agent, VX-gas, sprayed into his face while at Malaysia’s Kuala Lumpur International Airport. According to the Council on Foreign Relations (CFR), VX is the most toxic nerve agent ever synthesized. The CFR (founded in 1921) is a United States 4900-member organization, nonprofit, publisher, and think tank specializing in U.S. foreign policy and international affairs. The median lethal dose (LD50) of VX due to skin contact (not ingestion) for humans is estimated to be about 10 mg or 0.00035 ounces (that’s about 1/20 of a drop of liquid!). The median lethal airborne concentration (LC50) for this material, for which humans would inhale, is estimated to be 30 – 50 milligrams per cubic meter for only one minute! Typically, inhalation exposures are measured over an 8-hour time period. Yet, the effectiveness of VX is measured as an airborne exposure contaminant within a minute time period! VX is one a of number of chemical substances that is classified as a nerve agent. The principal nerve agents are sarin (GB), soman (GD), tabun (GA), and VX. They are manmade compounds that have been manufactured for the sole purpose to be used in chemical warfare. Nerve agents are organophosphorus compounds and therefore, are similar in mechanism of action as a number of pesticides; some of the most notable being malathion, parathion, and diazinon. As its name implies, these chemicals have a phosphorus atom connected to an organic molecule; the molecular variations of these materials are quite numerous. -
Review of Azinphos-Methyl Was Undertaken by the Office of Chemical Safety (OCS), Which Considered All the Toxicological Data and Information Submitted for the Review
The reconsideration of the active constituent azinphos-methyl, registrations of products containing azinphos-methyl and approvals of their associated labels PRELIMINARY REVIEW FINDINGS Volume 1: Review Summary OCTOBER 2006 Canberra Australia Azinphos-methyl review – Preliminary Review Findings © Australian Pesticides & Veterinary Medicines Authority 2006 This work is copyright. Apart from any use permitted under the Copyright Act 1968, no part may be reproduced without permission from the Australian Pesticides & Veterinary Medicines Authority. The Australian Pesticides & Veterinary Medicines Authority publishes this preliminary review findings report for the active constituent azinphos-methyl and products containing azinphos- methyl. For further information about this review or the Pesticides Review Program, contact: Manager Chemical Review Australian Pesticides & Veterinary Medicines Authority PO Box E 240 KINGSTON ACT 2604 Australia Telephone: 61 2 6272 3213 Facsimile: 61 2 6272 3218 Email: [email protected] APVMA web site: http://www.apvma.gov.au i Azinphos-methyl review – Preliminary Review Findings FOREWORD The Australian Pesticides & Veterinary Medicines Authority (APVMA) is an independent statutory authority with responsibility for the regulation of agricultural and veterinary chemicals in Australia. Its statutory powers are provided in the Agvet Codes scheduled to the Agricultural and Veterinary Chemicals Code Act 1994. The APVMA can reconsider the approval of an active constituent, the registration of a chemical product or -
Hawaii on Two Foliage Plants, Dwarf Brassaia Diazinon Plant After Spots
in Japan and England will be given by Tosh Fu- {Brassaia arboricola) and Dwarf Ti {Cordyline chikami of O.M. Scotts and Ray McMicken of B. terminalis 'Madameandre') to determine their Hayman Co., respectively. phototoxicity to selected insecticides and acara- cides. Plants, growing in 6-inch pots, were treated Farwest Show by submerging the aerial portions of the plant in Farwest Nursery, Garden, and Supply Show water suspensions of 7 pesticides for 15seconds. will be September 8-10, 1975, at the Memorial Granular formulations of 2 pesticides were ap Coliseum in Portland, Oregon. For information plied to the soil surface. Materials, at 2X stand contact: Farwest Nursery Show, Suite GA-7, ard rates, were as follows: 222 S.W. Harrison, Protland, OR. 97201. Amount formulation per: ASHS The 72d annual meeting of ASHS (American Material and formulation 1-gallon water 6-inch pot Society for Horticultural Science) will be held in chlorobenzilate 4E 2t — Honolulu, September 8 to 13, 1975, at the dicofol (Kelthane) 35WP 2T - Sheraton-Waikiki Hotel. Meeting concurrently Pentac 50WP 2T — with ASHS will be the American Horticulture carbaryl (Sevin) 50WP 2T - Society. The University of Hawaii will host the diazinon AG500 (48% EC) 2t - meeting with Dr. Richard Bullock, general chair dimethoate (Cygon) 2E 2t — man. Dr. Henry Nakasone will serve as assistant Volck Oil Supreme 2T - general chairman, Dr. Phil Parvin as local arrange aldicarb (Temik) 10G - 1.5t ments chairman, and Dr. Richard Criley as pro disulfoton (Di-Syston) 15G - 1.5t gram chairman. Neighbor island tours will be untreated controls - conducted following the meetings. -
Dichlorvos in Drinking-Water
WHO/FWC/WSH/16.44 Dichlorvos in Drinking-water Background document for development of WHO Guidelines for Drinking-water Quality World Health Organization 2016 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non- commercial distribution – should be addressed to WHO Press at the above address (fax: +41 22791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader.